Cargando…

The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel

Chicken red blood cells with fused Semliki Forest virus (SFV) proteins on the cell membrane were used in the hemolysis-in-gel (HIG) plates. Optimally the plate contained a 1.5 mm thick gel of 1% agarose with 1% red cells and 1 unit/ml gel of complement. 400 ng of SFV was fused to the red cells in 1...

Descripción completa

Detalles Bibliográficos
Autor principal: Vaananen, Pertti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 1982
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172477/
https://www.ncbi.nlm.nih.gov/pubmed/7042724
http://dx.doi.org/10.1016/0166-0934(82)90081-7
_version_ 1783524265028485120
author Vaananen, Pertti
author_facet Vaananen, Pertti
author_sort Vaananen, Pertti
collection PubMed
description Chicken red blood cells with fused Semliki Forest virus (SFV) proteins on the cell membrane were used in the hemolysis-in-gel (HIG) plates. Optimally the plate contained a 1.5 mm thick gel of 1% agarose with 1% red cells and 1 unit/ml gel of complement. 400 ng of SFV was fused to the red cells in 1 ml of the gel (about 20 virions fused to one red cell). Five μl of inactivated (56°C, 30 min) serum samples were pipetted into wells in the gel. After 20 h of incubation at 37°C the diameters of the hemolytic zones were directly proportional to the logarithm of the serum dilution. This made it possible to calculate the antibody titers for the samples using an experimental formula T = 10φk (T is the titer, φ the diameter in mm and k a variable coefficient, which had to be determined for each batch of the plates using a standard serum). Using regression and residual analyses, the formula was shown to fit the experimental results. The fusion-based HIG could be read after as early as 2 h of incubation. The specificity of the test was studied using antisera against Western equine encephalomyelitis, Eastern equine encephalomyelitis, Chikungunya and Uruma viruses, which all gave negative results in the SFV HIG test. Antisera against SFV E1 and E2 proteins were positive, but anti-E3 serum was negative when measured in the SFV HIG test.
format Online
Article
Text
id pubmed-7172477
institution National Center for Biotechnology Information
language English
publishDate 1982
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71724772020-04-22 The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel Vaananen, Pertti J Virol Methods Article Chicken red blood cells with fused Semliki Forest virus (SFV) proteins on the cell membrane were used in the hemolysis-in-gel (HIG) plates. Optimally the plate contained a 1.5 mm thick gel of 1% agarose with 1% red cells and 1 unit/ml gel of complement. 400 ng of SFV was fused to the red cells in 1 ml of the gel (about 20 virions fused to one red cell). Five μl of inactivated (56°C, 30 min) serum samples were pipetted into wells in the gel. After 20 h of incubation at 37°C the diameters of the hemolytic zones were directly proportional to the logarithm of the serum dilution. This made it possible to calculate the antibody titers for the samples using an experimental formula T = 10φk (T is the titer, φ the diameter in mm and k a variable coefficient, which had to be determined for each batch of the plates using a standard serum). Using regression and residual analyses, the formula was shown to fit the experimental results. The fusion-based HIG could be read after as early as 2 h of incubation. The specificity of the test was studied using antisera against Western equine encephalomyelitis, Eastern equine encephalomyelitis, Chikungunya and Uruma viruses, which all gave negative results in the SFV HIG test. Antisera against SFV E1 and E2 proteins were positive, but anti-E3 serum was negative when measured in the SFV HIG test. Published by Elsevier B.V. 1982-03 2002-11-13 /pmc/articles/PMC7172477/ /pubmed/7042724 http://dx.doi.org/10.1016/0166-0934(82)90081-7 Text en Copyright © 1982 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Vaananen, Pertti
The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel
title The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel
title_full The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel
title_fullStr The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel
title_full_unstemmed The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel
title_short The use of red cells with fused Semliki Forest virus envelope proteins in antibody determinations by hemolysis in gel
title_sort use of red cells with fused semliki forest virus envelope proteins in antibody determinations by hemolysis in gel
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172477/
https://www.ncbi.nlm.nih.gov/pubmed/7042724
http://dx.doi.org/10.1016/0166-0934(82)90081-7
work_keys_str_mv AT vaananenpertti theuseofredcellswithfusedsemlikiforestvirusenvelopeproteinsinantibodydeterminationsbyhemolysisingel
AT vaananenpertti useofredcellswithfusedsemlikiforestvirusenvelopeproteinsinantibodydeterminationsbyhemolysisingel